2021 tables: Institutions - biological sciences - corporate

The 2021 tables are based on Nature Index data from 1 January 2020 to 31 December 2020.

Table criteria

Request a badge Export CSV
# Institution Share 2019 Share 2020 Count 2020 Change in Adjusted Share* 2019–2020
1 BGI, China 9.12 7.34 50 -25.6%
2 Formosa Plastics Group, Taiwan 3.59 6.00 26 54.6%
3 Samsung Group, South Korea 2.55 2.43 29 -11.8%
4 Takeda Pharmaceutical Company Limited, Japan 3.11 2.16 14 -35.8%
5 Nippon Telegraph and Telephone Corporation (NTT), Japan 1.56 2.00 2 18.9%
6 China National Chemical Corporation (ChemChina), China 1.79 1.59 6 -17.8%
7 Advanced Telecommunications Research Institute International (ATR), Japan 1.08 1.31 4 12.9%
8 Kao Corporation, Japan 0.14 1.25 4 710.8%
9 The New Zealand Institute for Plant and Food Research Ltd., New Zealand 1.19 1.17 15 -9.0%
10 Otsuka Holdings Co., Ltd., Japan 1.18 1.08 6 -15.0%
11 China National Pharmaceutical Group (Sinopharm), China – 1.04 3 N/A
12 Astellas Pharma Inc., Japan 0.01 0.97 5 7731.1%
13 Cellivery, South Korea – 0.89 1 N/A
14 Wilmar International Limited, Singapore – 0.88 1 N/A
15 EnGeneIC Ltd., Australia – 0.85 1 N/A
16 Novogene Co., Ltd., China 0.34 0.84 12 127.0%
17 Daiichi Sankyo Co., Ltd., Japan 1.63 0.80 6 -54.5%
18 China State Shipbuilding Corporation Limited (CSSC), China 0.61 0.73 43 11.3%
19 Fosun Pharma, China – 0.71 1 N/A
20 JT Biohistory Research Hall (BRH), Japan – 0.64 2 N/A
21 Topchoice Group, China 0.85 0.64 10 -30.9%
22 GrandOmics Biosciences, China 0.30 0.61 2 85.1%
23 Tencent, China 0.20 0.60 3 179.7%
24 Takii and Company, Limited, Japan – 0.56 1 N/A
25 Sony Corporation, Japan 0.51 0.52 2 -5.5%
26 AmorePacific Corporation, South Korea – 0.50 1 N/A
27 Mabwell (Shanghai) Bioscience Co., Ltd., China – 0.48 1 N/A
28 Singlera Genomics Inc., China 0.05 0.47 1 723.7%
28 Zhejiang NHU Company Ltd., China – 0.47 1 N/A
29 WuXi AppTec, China 0.57 0.45 9 -27.4%
30 Ajinomoto Co., Inc., Japan 0.01 0.45 4 3499.8%
31 Sinovac Biotech Co., Ltd., China 0.09 0.44 1 348.8%
32 Institute of Environmental Science and Research (ESR), New Zealand – 0.40 1 N/A
33 Beijing Solidwill Sci-Tech Co., Ltd., China – 0.38 1 N/A
34 Metabolomics Australia (MA), Australia 0.35 0.38 5 0.3%
35 Doctor's Choice Co., Ltd., Japan – 0.38 1 N/A
36 FiberHome Technologies Group, China 0.39 0.37 12 -13.4%
37 Tata Group, India – 0.35 2 N/A
38 Shimadzu Corporation, Japan 0.14 0.35 4 125.3%
39 Kowa Company, Ltd., Japan 0.24 0.35 4 34.6%
40 Clinomics Inc., South Korea – 0.35 2 N/A
41 Kansai Electric Power Co., Inc., Japan 0.14 0.35 5 134.6%
42 Amine Pharma Research Institute Co., Ltd., Japan – 0.34 2 N/A
43 Il Yang Pharmaceutical Co. Ltd., South Korea – 0.33 1 N/A
43 Clarity Pharmaceuticals, Australia – 0.33 1 N/A
44 Hamamatsu Photonics K.K., Japan 0.03 0.33 3 876.0%
45 Theragen Etex Bio Institute, South Korea 0.02 0.32 2 1133.2%
46 Scion, New Zealand 0.14 0.31 7 112.2%
47 Hangzhou Dixiang Import & Export Co. Ltd, China – 0.31 1 N/A
48 ExoStemTech Inc., South Korea – 0.31 1 N/A
49 JEOL Ltd., Japan 0.14 0.30 7 104.7%
50 Konica Minolta, Inc., Japan 0.26 0.29 4 2.4%

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 82 natural-science journals through 2022, in 2023 64 health-science journals were added to the Index. The 146 journals in the Nature Index were selected on reputation by an independent panel of leading scientists in their fields.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at nature.com/nature-index/.
  5. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.

*The change in adjusted Share accounts for the small annual variation in the total number of articles in Nature Index journals. Share values have been adjusted to 2022 levels to calculate the percentage change. For more information on the adjustment, please see the Adjusted metric explainer.


Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.